Healthy volunteers help test new drug YN001 in first human study
NCT ID NCT07190885
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This early-stage study is testing a new drug called YN001 in 24 healthy adults aged 18 to 65. The goal is to measure how the drug moves through the body, how long it stays, and whether it causes any side effects. Participants receive a single dose and are monitored closely. This study does not aim to treat any disease—it simply gathers important safety and drug-level information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research
RECRUITINGAdelaide, South Australia, Australia
Contact
Conditions
Explore the condition pages connected to this study.